Filed
April 21, 2025
Lobbying Activities
Health IssuesView all
Issues related to drug pricing; pharmaceutical supply chain; modernizational of prescribing information for physicians and pharmacists; Increasing Trasnparency in Generic Drug Applications, S.1302 and H.R. 1843; Part D Formulary Design and Generic Drug Testing
Lobbyists (5)
ASHLEY DAVIS
Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President
NewKRISTI REMINGTON
Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
NewSHIMON STEIN
Senior Policy Advisory, House Majority Leader Eric Cantor, Program Manager, US Department of Justice, Legislative Correspondent, Senator John Ashcroft; Paid Intern, Representative Robert Aderholt
New